Pre-Clinical Investigation of Repaglinide Nanoparticles in High Fat Diet with streptozotocin induced memory impaired rats
No Thumbnail Available
Date
2023-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Diabetes Mellitus is a metabolic disorder characterized by insulin resistance with several metabolic abnormalities which trigger neuronal complications, neurodegeneration, and cognitive impairments. Repaglinide (REP) is an insulinotropic, neuroprotective agent with short-action and poor absorption characteristics. Hence, the present study was aimed to investigate the efficacy of REP-loaded lipid polymer-hybrid nanoparticles (REP-LPHNPs) in High Fat Diet low dose of Streptozotocin (HFD-STZ) induced cognitive deficits wistar rats model.
Description
Keywords
Pharmacy, Streptozotocin, Repaglinide (REP)